The biotech IPO train keeps chug­ging, as Virios prices $30M pub­lic de­but

Chest­nuts roast­ing on an open fire, biotechs keep pric­ing IPOs.

Virios Ther­a­peu­tics priced its pub­lic de­but on Thurs­day, bring­ing home $30 mil­lion and con­tribut­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER